132 related articles for article (PubMed ID: 7906926)
1. Inhibitory effect of levocabastine on allergen-induced increase of nasal reactivity to histamine and cell influx.
Pazdrak K; Górski P; Ruta U
Allergy; 1993 Nov; 48(8):598-601. PubMed ID: 7906926
[TBL] [Abstract][Full Text] [Related]
2. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
[TBL] [Abstract][Full Text] [Related]
3. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect.
Bernardini R; Novembre E; Mugnaini L; Rossi ME; Vierucci A
Allergy Asthma Proc; 1998; 19(2):75-80. PubMed ID: 9578915
[TBL] [Abstract][Full Text] [Related]
5. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
Holmberg K; Pipkorn U; Bake B; Blychert LO
Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
[TBL] [Abstract][Full Text] [Related]
6. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
Janssens MM
Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
[TBL] [Abstract][Full Text] [Related]
7. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
Janssens MM; Vanden Bussche G
Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
[TBL] [Abstract][Full Text] [Related]
8. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test.
Pécoud A; Zuber P; Kolly M
Int Arch Allergy Appl Immunol; 1987; 82(3-4):541-3. PubMed ID: 2883132
[TBL] [Abstract][Full Text] [Related]
9. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
Bachert C; Wagenmann M; Vossen-Holzenkamp S
Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
[TBL] [Abstract][Full Text] [Related]
10. The effect of levocabastine nasal spray in nasal provocation tests.
Palma-Carlos AG; Palma-Carlos ML; Rombaut N
Int J Clin Pharmacol Res; 1988; 8(1):25-30. PubMed ID: 2896636
[TBL] [Abstract][Full Text] [Related]
11. The effect of levocabastine and furosemide pretreatment on hyperreactive response after nasal provocation with hypotonic aerosol in subjects with allergic rhinitis.
Anzic SA; Dzepina D; Kalogjera L
Eur Arch Otorhinolaryngol; 2007 Nov; 264(11):1309-14. PubMed ID: 17618447
[TBL] [Abstract][Full Text] [Related]
12. Effects of loratadine and terfenadine on the induced nasal allergic reaction.
Baroody FM; Lim MC; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):309-16. PubMed ID: 8607960
[TBL] [Abstract][Full Text] [Related]
13. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
Borum S; Nielsen K; Bisgaard H; Mygind N
Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist].
Akiyoshi M; Shigeoka T; Torii S; Maki E; Enomoto S; Takahashi H; Hirano F
Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):175-84. PubMed ID: 11915520
[TBL] [Abstract][Full Text] [Related]
15. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions.
Corren J; Rachelefsky G; Spector S; Schanker H; Siegel S; Holton D; Karcher K; Travers S
J Allergy Clin Immunol; 1999 Apr; 103(4):574-80. PubMed ID: 10200003
[TBL] [Abstract][Full Text] [Related]
16. Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen.
Kolly M; Pécoud A
Br J Clin Pharmacol; 1986 Oct; 22(4):389-94. PubMed ID: 2876723
[TBL] [Abstract][Full Text] [Related]
17. Topical levocabastine for the treatment of perennial allergic rhinitis.
Elwany S; Bassiouny M
J Laryngol Otol; 1997 Oct; 111(10):935-40. PubMed ID: 9425481
[TBL] [Abstract][Full Text] [Related]
18. Effects of cetirizine on substance P release in patients with perennial allergic rhinitis.
Shirasaki H; Watanabe K; Kanaizumi E; Sato J; Konno N; Narita S; Himi T
Ann Otol Rhinol Laryngol; 2004 Dec; 113(12):941-5. PubMed ID: 15633894
[TBL] [Abstract][Full Text] [Related]
19. Effect of ipratropium on nasal reactivity to histamine and eosinophil influx in perennial allergic rhinitis.
Górski P; Pazdrak K; Ruta U
Eur J Clin Pharmacol; 1993; 44(6):545-7. PubMed ID: 8405010
[TBL] [Abstract][Full Text] [Related]
20. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
Dechant KL; Goa KL
Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
